Corium, Inc. clinical trials
The registry lists 8 studies whose lead sponsor is Corium, Inc. or one of 1 company grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 8, 2026.
Our grouping of 2 registry names, not the registry’s. See them and correct one ↓
- 8studies on the registry
- 0open to participants now
What it is testing
The drugs Corium, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 6
All 8 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed8100%
Over the years
- 16
- 217
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Corium, Inc..
- Corium, Inc.8 studiesSame company
Something wrong?
- Corium Innovations, Inc.0 studies →Divested — left Corium, Inc., Oct 2022 · 6 more first submitted after it left, not counted · source ↗
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 8 of 8.
- A Safety/Tolerability and PK Study With Azstarys® in Children With ADHDCompletedNCT05721235Phase 4
- An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHDCompletedNCT05685732Phase 4
- Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy VolunteersCompletedNCT04617782Phase 1
- A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery SystemCompletedNCT03397862Phase 1
- A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)CompletedNCT03438604Phase 1
- A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body LocationsCompletedNCT03432195Phase 1
- A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®CompletedNCT03259958Phase 1
- A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®CompletedNCT02968719Phase 1